1. Home
  2. EVLV vs STOK Comparison

EVLV vs STOK Comparison

Compare EVLV & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVLV
  • STOK
  • Stock Information
  • Founded
  • EVLV 2013
  • STOK 2014
  • Country
  • EVLV United States
  • STOK United States
  • Employees
  • EVLV N/A
  • STOK N/A
  • Industry
  • EVLV Computer peripheral equipment
  • STOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVLV Technology
  • STOK Health Care
  • Exchange
  • EVLV Nasdaq
  • STOK Nasdaq
  • Market Cap
  • EVLV 1.2B
  • STOK 1.1B
  • IPO Year
  • EVLV N/A
  • STOK 2019
  • Fundamental
  • Price
  • EVLV $8.20
  • STOK $23.68
  • Analyst Decision
  • EVLV Strong Buy
  • STOK Strong Buy
  • Analyst Count
  • EVLV 4
  • STOK 6
  • Target Price
  • EVLV $8.88
  • STOK $26.60
  • AVG Volume (30 Days)
  • EVLV 3.8M
  • STOK 1.0M
  • Earning Date
  • EVLV 08-14-2025
  • STOK 11-04-2025
  • Dividend Yield
  • EVLV N/A
  • STOK N/A
  • EPS Growth
  • EVLV N/A
  • STOK N/A
  • EPS
  • EVLV N/A
  • STOK 0.91
  • Revenue
  • EVLV $121,011,000.00
  • STOK $199,893,000.00
  • Revenue This Year
  • EVLV $31.07
  • STOK $415.58
  • Revenue Next Year
  • EVLV $17.67
  • STOK N/A
  • P/E Ratio
  • EVLV N/A
  • STOK $26.17
  • Revenue Growth
  • EVLV 36.64
  • STOK 1218.82
  • 52 Week Low
  • EVLV $2.04
  • STOK $5.35
  • 52 Week High
  • EVLV $8.91
  • STOK $23.96
  • Technical
  • Relative Strength Index (RSI)
  • EVLV 59.39
  • STOK 87.44
  • Support Level
  • EVLV $7.73
  • STOK $18.80
  • Resistance Level
  • EVLV $8.60
  • STOK $22.39
  • Average True Range (ATR)
  • EVLV 0.37
  • STOK 1.19
  • MACD
  • EVLV -0.08
  • STOK 0.24
  • Stochastic Oscillator
  • EVLV 47.69
  • STOK 88.86

About EVLV Evolv Technologies Holdings Inc.

Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: